Collection: Thromboxane A2 Synthase Inhibitors
Thromboxane A2 Synthase Inhibitors — compiles thromboxane A2 synthase enzyme inhibitor compounds, such as seratrodast and ozagrel, which play a role in regulating the conversion of prostaglandin H2 into thromboxane A2, an important mediator in platelet aggregation and vascular smooth muscle contraction.
This class of thromboxane A2 synthase inhibitors is studied by cardiovascular and pulmonary pharmacology researchers in experiments related to platelet function, vascular tone, and airway constriction models. Compounds such as ozagrel and its salt derivatives are often used as research tools in in vitro and in vivo studies exploring the arachidonic acid pathway and platelet regulation.
Example products in this collection: TCI S0943 112665-43-7 Seratrodast, TCI O0610 82571-53-7 Ozagrel, TCI O0660 189224-26-8 Ozagrel Sodium.
Pay attention to the salt or free base form (for example ozagrel versus ozagrel sodium), the analytical purity level, and the compound's stability against light and storage temperature, especially for applications that require consistent results between batches. All products are genuine Tokyo Chemical Industry (TCI) Japan products, with purity, packaging, and storage conditions listed on the page of each item.
Other parallel categories under Antithrombotic Ingredients (for Research and Experimental Use), often used together in one laboratory workflow:
Back to Antithrombotic Ingredients (for Research and Experimental Use). For large-volume procurement, special packaging, or specific grades, contact the AMI Scientific team — official TCI Japan distributor in Indonesia — to check availability and lead time directly from Japan.
